EOEvren Oktem

Evren Oktem

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Evren Oktem has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Microfluidic Brillouin platform for frequency-resolved mechanics of complex fluids

    by Chingis Kharmyssov, Vsevolod Cheburkanov, Mykyta Kizilov, Brian Sanders, Evren Oktem, Ankit Kumar, Abhishek Jain, Vladislav V. Yakovlev

    We introduce an integrated microfluidic platform that combines pressure-flow rheology with depth-resolved Brillouin microspectroscopy to investigate complex fluids in extensive frequency ranges. Apparent viscosity is measured via calibrated pressure-flow in a rectangular polydimethylsiloxane microchannel, while GHz-frequency Brillouin spectroscopy probes longitudinal mechanics under identical steady-flow conditions. Using semi-dilute methylcellulose solutions in a cell-culture medium as a model, we reveal mild shear-thinning behavior, whereas the Brillouin frequency shift and linewidth values remain constant throughout the flow rate range, mainly influenced by polymer concentration. This confirms the decoupling between steady-shear and GHz-frequency acoustic responses observed previously. The platform offers a compact, calibrated approach for frequency-resolved mechanical analysis of flowing soft materials and perfused media.

  • Open Access

    Patient-derived resources for decoding and targeting brain metastases ecosystems

    by Manuel Valiente, Lal Era Aydoğan, Nisan Feigin, Clara Gahn, Carolina Hernandez-Oliver, Friedrich Milling, Evren Oktem, Carmen Ortega-Sabater, Neibla Priego, Alessia Andrea Ricci, et al.

    Brain metastases (BrM) affect up to 30% of patients with solid tumors, yet durable intracranial control remains rare, and the biological drivers of this poor prognosis are incompletely understood. Patient-derived resources, such as clinical cohorts, biobanks, functional ex vivo models, and multi-omic platforms, are central to closing this gap, but their generation and integration face substantial logistical and technical hurdles. Drawing on the RISEbrain consortium's experience, this Perspective examines BrM-focused cohorts and biobanks, highlighting the underused potential of rapid autopsy programs to capture early metastatic seeding. We discuss patient-derived organotypic cultures and emerging organoid-based "avatar" systems as functional platforms for therapeutic profiling, alongside the complementary strengths of bulk and single-cell/-nucleus transcriptomics. We outline how spatial transcriptomics and proteomics are resolving the architecture of the BrM microenvironment, and assess liquid biopsy approaches, including emerging photonic biosensors, for non-invasive monitoring. Together, these resources form an interdependent toolkit whose coordinated deployment will advance early detection, prevention, and precision treatment of BrM.